Literature DB >> 10572472

Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group.

E Franco1, L Villa, T Rohan, A Ferenczy, M Petzl-Erler, G Matlashewski.   

Abstract

This article reports on a large longitudinal study, begun in 1993, of the natural history of human papillomavirus (HPV) infection and cervical neoplasia in a population of low-income women in São Paulo, Brazil, a city with one of the highest risks worldwide for cervical cancer. Known as the Ludwig-McGill cohort study, the epidemiological investigation focuses on persistent infection with oncogenic HPV types as the precursor event leading to cervical neoplasia. The objectives of this study are to: 1) study the epidemiology of persistent cervical HPV infection in asymptomatic women, 2) investigate whether persistent HPV infection increases risk of low-grade and high-grade cervical lesions, 3) search for determinants of persistent HPV infection, 4) search for molecular variants of HPV that may be associated with an increased risk of lesions, 5) investigate whether viral burden is correlated with persistent infections and with lesion risk, 6) study the antibody response to HPV as a predictor of persistence and lesion progression, and 7) examine the role of HLA typing and codon 72 p53 gene polymorphism in mediating HPV persistence and lesion severity. The study accrued 2,528 female subjects through March 1997. Subjects were followed up every 4 months in the first year, with twice-yearly return visits to take place in subsequent years. Participants undergo a questionnaire-based interview, have a cervical specimen taken for Pap cytology and HPV testing, and have a blood sample drawn for HPV antibody testing. A cervicography is performed once in the first year and every two years thereafter. In this article we describe the design and methods of the study, provide baseline cohort characteristics, and present a preliminary assessment of the prognostic value of baseline HPV status.

Entities:  

Mesh:

Year:  1999        PMID: 10572472     DOI: 10.1590/s1020-49891999000900001

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  29 in total

1.  Human papillomavirus genotyping after denaturation of specimens for Hybrid Capture 2 testing: feasibility study for the HPV persistence and progression cohort.

Authors:  Brandon J LaMere; Janet Kornegay; Barbara Fetterman; Mark Sadorra; Jen Shieh; Philip E Castle
Journal:  J Virol Methods       Date:  2007-07-27       Impact factor: 2.014

2.  Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity.

Authors:  Helen Trottier; Silvaneide Ferreira; Patricia Thomann; Maria C Costa; Joao S Sobrinho; José Carlos M Prado; Thomas E Rohan; Luisa L Villa; Eduardo L Franco
Journal:  Cancer Res       Date:  2010-10-26       Impact factor: 12.701

3.  Circulating biomarkers of iron storage and clearance of incident human papillomavirus infection.

Authors:  Erin M Siegel; Nitin Patel; Beibei Lu; Ji-Hyun Lee; Alan G Nyitray; Xi Huang; Luisa L Villa; Eduardo L Franco; Anna R Giuliano
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-03-16       Impact factor: 4.254

4.  Assessment of the performance of algorithms for cervical cancer screening: evidence from the Ludwig-McGill cohort study.

Authors:  M Chevarie-Davis; A V Ramanakumar; A Ferenczy; L L Villa; E L Franco
Journal:  Gynecol Oncol       Date:  2012-12-09       Impact factor: 5.482

5.  Evaluation of human papillomavirus type replacement postvaccination must account for diagnostic artifacts: masking of HPV52 by HPV16 in anogenital specimens.

Authors:  Joseph E Tota; Agnihotram V Ramanakumar; Luisa L Villa; Harriet Richardson; Ann N Burchell; Anita Koushik; Marie-Hélène Mayrand; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-10-02       Impact factor: 4.254

6.  Evaluation of the FTA carrier device for human papillomavirus testing in developing countries.

Authors:  Paula Gonzalez; Bernal Cortes; Wim Quint; Aimée R Kreimer; Carolina Porras; Ana Cecilia Rodríguez; Silvia Jimenez; Rolando Herrero; Linda Struijk; Allan Hildesheim; Willem Melchers
Journal:  J Clin Microbiol       Date:  2012-09-19       Impact factor: 5.948

7.  Invited commentary: Human papillomavirus infection and risk of cervical precancer--using the right methods to answer the right questions.

Authors:  Eduardo L Franco; Joseph Tota
Journal:  Am J Epidemiol       Date:  2009-12-10       Impact factor: 4.897

8.  Use of the normalized absorbance ratio as an internal standardization approach to minimize measurement error in enzyme-linked immunosorbent assays for diagnosis of human papillomavirus infection.

Authors:  Agnihotram V Ramanakumar; Patricia Thomann; Joao M Candeias; Silvaneide Ferreira; Luisa L Villa; Eduardo L Franco
Journal:  J Clin Microbiol       Date:  2010-01-06       Impact factor: 5.948

9.  Validation of dot blot hybridization and denaturing high performance liquid chromatography as reliable methods for TP53 codon 72 genotyping in molecular epidemiologic studies.

Authors:  Tatiana Rabachini; Helen Trottier; Eduardo L Franco; Luisa L Villa
Journal:  BMC Genet       Date:  2010-05-26       Impact factor: 2.797

Review 10.  Human papillomavirus and HPV vaccines: a review.

Authors:  F T Cutts; S Franceschi; S Goldie; X Castellsague; S de Sanjose; G Garnett; W J Edmunds; P Claeys; K L Goldenthal; D M Harper; L Markowitz
Journal:  Bull World Health Organ       Date:  2007-09       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.